Pyxis Oncology Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Pyxis Oncology Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- PYXS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001782223
Board of directors
-
Darren S. Cline · DirectorSince 2023
-
Freda C. Lewis-Hall · DirectorSince 2023
-
Jakob Dupont · DirectorSince 2023
-
John L. Flavin · DirectorSince 2023
-
Lara Sullivan · Director · Chief Executive OfficerSince 2023
-
Michael A. Metzger · DirectorSince 2024
-
Rachel Humphrey · DirectorSince 2023
-
Santhosh Palani · DirectorSince 2024
-
Thomas Civik · DirectorSince 2023
Chief executives
Lara Sullivan
· President and CEO
Dates unknown
Board connections
5 of this board's directors also sit on 5 other boards.
- via Santhosh Palani
- via Jakob Dupont
- via Freda C. Lewis-Hall
- via Darren S. Cline
- via Michael A. Metzger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 26, 2024 | Connealy Pamela Yanchik Officer (CFO & COO) | Open-market purchase | +5,450 | $2.00 | $10,900 |
| Nov 26, 2024 | Connealy Pamela Yanchik Officer (CFO & COO) | Open-market purchase | +83,400 | $1.96 | $163,464 |
| Jun 7, 2024 | Santhosh Palani Director | Grant or award | +6,000 | — | — |
| Mar 26, 2024 | Connealy Pamela Yanchik Officer (CFO & COO) | Grant or award | +328,710 | — | — |
| Mar 26, 2024 | Darren S. Cline Director | Grant or award | +35,219 | — | — |
| Mar 26, 2024 | John L. Flavin Director | Grant or award | +35,219 | — | — |
| Mar 26, 2024 | Freda C. Lewis-Hall Director | Grant or award | +35,219 | — | — |
| Mar 26, 2024 | Jakob Dupont Director | Grant or award | +38,741 | — | — |
| Mar 26, 2024 | Rachel Humphrey Director | Grant or award | +38,741 | — | — |
| Mar 26, 2024 | Wadhane Jitendra Officer (SVP, Chief Accounting Officer) | Grant or award | +131,484 | — | — |
| Nov 29, 2023 | Connealy Pamela Yanchik Officer (CFO and COO) | Shares withheld for tax | −36,949 | $1.40 | $51,729 |
| Nov 15, 2023 | Wadhane Jitendra Officer (Chief Accounting Officer) | Grant or award | +40,000 | — | — |
| Sep 28, 2023 | Connealy Pamela Yanchik Officer (CFO and COO) | Open-market purchase | +8,000 | $1.87 | $14,960 |
| Sep 27, 2023 | Wadhane Jitendra Officer (Chief Accounting Officer) | Open-market purchase | +2,500 | $1.87 | $4,675 |
| Sep 27, 2023 | Connealy Pamela Yanchik Officer (CFO and COO) | Open-market purchase | +6,426 | $1.85 | $11,888 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.